Clinical trials
Colorectal Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
338 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 6 |
| 2002 | 2 |
| 2003 | 12 |
| 2004 | 7 |
| 2005 | 7 |
| 2006 | 10 |
| 2007 | 8 |
| 2008 | 10 |
| 2009 | 17 |
| 2010 | 8 |
| 2011 | 16 |
| 2012 | 13 |
| 2013 | 11 |
| 2014 | 14 |
| 2015 | 16 |
| 2016 | 13 |
| 2017 | 16 |
| 2018 | 12 |
| 2019 | 20 |
| 2020 | 16 |
| 2021 | 20 |
| 2022 | 16 |
| 2023 | 13 |
| 2024 | 14 |
| 2025 | 24 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 174 |
| Recruiting | 56 |
| Terminated | 41 |
| Unknown status | 32 |
| Active, not recruiting | 26 |
| Not yet recruiting | 5 |
| Withdrawn | 2 |
| Suspended | 1 |
| No longer available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 16 |
| European Organisation for Research and Treatment of Cancer - EORTC | 12 |
| Hoffmann-La Roche | 11 |
| Charite University, Berlin, Germany | 10 |
| Eli Lilly and Company | 10 |
| Pfizer | 10 |
| AIO-Studien-gGmbH | 9 |
| Amgen | 9 |
| Bayer | 9 |
| AstraZeneca | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 338 |
| Colonic Neoplasms | 42 |
| Neoplasm Metastasis | 40 |
| Neoplasms | 33 |
| Rectal Neoplasms | 32 |
| Carcinoma, Non-Small-Cell Lung | 30 |
| Pancreatic Neoplasms | 24 |
| Breast Neoplasms | 22 |
| Stomach Neoplasms | 22 |
| Ovarian Neoplasms | 18 |
Trials
Showing 76 to 100 of 338. Each trial links to its page on Pharma Observatory.
238 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.